Geode Capital Management
CPAH

Geode Capital Management’s Counterpath Corp CPAH Stock Holding History

Geode Capital Management’s Portfolio CPAH Stock Details CPAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-17,127
Closed -$16K – 4284
2019
Q4 		$16K Hold
17,127
– – ﹤0.01% 4176
2019
Q3 		$19K Hold
17,127
– – ﹤0.01% 4152
2019
Q2 		$26K Buy
+17,127
New +$28.3K ﹤0.01% 4146

Other funds holding CPAH

BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management's CPAH Position: Q1 2020 in Review

Geode Capital Management sold out of Counterpath Corp (CPAH) in Q1 2020, closing a stake of 17,127 shares — an estimated $16K sold.

Geode Capital Management first reported a position in CPAH in Q2 2019 and held it in 3 quarters. The position peaked at $26K in Q2 2019. 10 funds tracked by Wall St. Rank hold CPAH as of Q1 2020.

  • Geode Capital Management reported no remaining Counterpath Corp position as of Q1 2020 after selling out during the quarter.
  • Geode Capital Management sold 17,127 Counterpath Corp shares in Q1 2020, an estimated $16K.
  • Geode Capital Management first reported a position in Counterpath Corp in Q2 2019 and held it in 3 quarters.
  • Geode Capital Management's Counterpath Corp position peaked at $26K in Q2 2019.
  • 10 funds tracked by Wall St. Rank held Counterpath Corp as of Q1 2020.

Based on Geode Capital Management's 13F filing for Q1 2020, filed 14 May 2020.